Evidence map›Paper›PMID 34722636›Full record

ArticleFrontiers in molecular biosciences2021

Transcriptomic Analysis Identifies Complement Component 3 as a Potential Predictive Biomarker for Chemotherapy Resistance in Colorectal Cancer.

Xiao-Shun He, Sheng-Yi Zou, Jia-Lu Yao, Wangjianfei Yu, Zhi-Yong Deng, Jing-Ru Wang, Wen-Juan Gan, Shan Wan, Xiao-Qin Yang, Hua Wu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xiao-Shun HeDepartment of Pathology, Medical College of Soochow University and The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
Sheng-Yi ZouDepartment of Endocrinology and Metabolism, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
Jia-Lu YaoDepartment of Cardiology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
Wangjianfei YuDepartment of Bioinformatics, Medical College of Soochow University, Soochow University, Suzhou, China.
Zhi-Yong DengDepartment of Pathology, The First People's Hospital of Kunshan, Kunshan, China.
Jing-Ru WangDepartment of Pathology, Medical College of Soochow University and The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
Wen-Juan GanDepartment of Pathology, Dushu Lake Hospital Affiliated of Soochow University, Soochow University, Suzhou, China.
Shan WanDepartment of Pathology, Medical College of Soochow University and The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
Xiao-Qin YangDepartment of Bioinformatics, Medical College of Soochow University, Soochow University, Suzhou, China.
Hua WuDepartment of Pathology, Medical College of Soochow University and The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
Soochow University · CNFirst Affiliated Hospital of Soochow University · CNJiangsu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

C3colorectal canceroxaliplatin resistanceprognosistranscriptomic analysis

Identifiers

PMID34722636
PMCPMC8554154
OpenAlexW3206093017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.